DE69121000T2 - Alpha-Mannosidase- und fucosidase-Hemmer - Google Patents

Alpha-Mannosidase- und fucosidase-Hemmer

Info

Publication number
DE69121000T2
DE69121000T2 DE69121000T DE69121000T DE69121000T2 DE 69121000 T2 DE69121000 T2 DE 69121000T2 DE 69121000 T DE69121000 T DE 69121000T DE 69121000 T DE69121000 T DE 69121000T DE 69121000 T2 DE69121000 T2 DE 69121000T2
Authority
DE
Germany
Prior art keywords
group
hydroxymethyl
compound according
acid
cyclopentyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69121000T
Other languages
German (de)
English (en)
Other versions
DE69121000D1 (de
Inventor
Robert A Farr
Norton P Peet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69121000D1 publication Critical patent/DE69121000D1/de
Application granted granted Critical
Publication of DE69121000T2 publication Critical patent/DE69121000T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69121000T 1990-04-12 1991-04-11 Alpha-Mannosidase- und fucosidase-Hemmer Expired - Fee Related DE69121000T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50887590A 1990-04-12 1990-04-12

Publications (2)

Publication Number Publication Date
DE69121000D1 DE69121000D1 (de) 1996-08-29
DE69121000T2 true DE69121000T2 (de) 1996-12-19

Family

ID=24024437

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69121000T Expired - Fee Related DE69121000T2 (de) 1990-04-12 1991-04-11 Alpha-Mannosidase- und fucosidase-Hemmer

Country Status (19)

Country Link
EP (1) EP0451834B1 (enrdf_load_stackoverflow)
JP (1) JP2955057B2 (enrdf_load_stackoverflow)
KR (1) KR100197382B1 (enrdf_load_stackoverflow)
CN (1) CN1033638C (enrdf_load_stackoverflow)
AT (1) ATE140692T1 (enrdf_load_stackoverflow)
AU (1) AU646855B2 (enrdf_load_stackoverflow)
CA (1) CA2040058C (enrdf_load_stackoverflow)
DE (1) DE69121000T2 (enrdf_load_stackoverflow)
DK (1) DK0451834T3 (enrdf_load_stackoverflow)
ES (1) ES2092520T3 (enrdf_load_stackoverflow)
FI (1) FI109200B (enrdf_load_stackoverflow)
GR (1) GR3020934T3 (enrdf_load_stackoverflow)
HU (1) HU213396B (enrdf_load_stackoverflow)
IE (1) IE75195B1 (enrdf_load_stackoverflow)
IL (1) IL97814A (enrdf_load_stackoverflow)
NO (1) NO175856C (enrdf_load_stackoverflow)
NZ (1) NZ237734A (enrdf_load_stackoverflow)
PT (1) PT97339B (enrdf_load_stackoverflow)
ZA (1) ZA912588B (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
CN1251588A (zh) * 1996-10-01 2000-04-26 格里科设计公司 新的苦马豆素的3,5和/或6取代的类似物、制备其的方法及作为治疗剂的应用
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
JP2001521036A (ja) * 1997-10-24 2001-11-06 グリコデザイン インコーポレイテッド スワインソニン塩の合成
CN102905716B (zh) * 2010-01-28 2016-06-01 雷普特制药公司 以受体相关蛋白(rap)肽-岩藻糖苷酶抑制剂偶联物治疗肝病症的方法
CN101870992A (zh) * 2010-06-21 2010-10-27 天津科技大学 利用基因工程菌耦合发酵合成gdp-岩藻糖的方法
CN102286608B (zh) * 2011-06-08 2014-06-25 郑州安图生物工程股份有限公司 衣原体诊断方法和试剂盒

Also Published As

Publication number Publication date
JP2955057B2 (ja) 1999-10-04
NO175856B (enrdf_load_stackoverflow) 1994-09-12
EP0451834A3 (en) 1993-10-20
NZ237734A (en) 1993-05-26
AU7416491A (en) 1991-10-17
ES2092520T3 (es) 1996-12-01
HU213396B (en) 1997-06-30
CN1055732A (zh) 1991-10-30
NO911419L (no) 1991-10-14
CA2040058C (en) 2001-10-23
IL97814A0 (en) 1992-06-21
DE69121000D1 (de) 1996-08-29
AU646855B2 (en) 1994-03-10
CA2040058A1 (en) 1991-10-13
FI109200B (fi) 2002-06-14
HU911196D0 (en) 1991-10-28
KR100197382B1 (ko) 1999-06-15
ATE140692T1 (de) 1996-08-15
FI911751L (fi) 1991-10-13
CN1033638C (zh) 1996-12-25
KR910018341A (ko) 1991-11-30
NO911419D0 (no) 1991-04-11
NO175856C (no) 1994-12-21
PT97339A (pt) 1992-01-31
IE911229A1 (en) 1991-10-23
JPH04234834A (ja) 1992-08-24
IL97814A (en) 1995-08-31
PT97339B (pt) 1998-08-31
FI911751A0 (fi) 1991-04-11
DK0451834T3 (da) 1996-08-26
EP0451834B1 (en) 1996-07-24
HUT60994A (en) 1992-11-30
ZA912588B (en) 1992-01-29
GR3020934T3 (en) 1996-12-31
EP0451834A2 (en) 1991-10-16
IE75195B1 (en) 1997-08-27

Similar Documents

Publication Publication Date Title
DE69323773T2 (de) Antikonvulsive sorbopyranose sulfamate
DE69328435T2 (de) Neues sphingolglycolipid und verwendung davon
DE69508463T2 (de) Propiophenonderivate und Verfahren zu deren Herstellung
EP0109020A2 (de) Neue Derivate tricyclischer Aminosäuren, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung, sowie neue bicyclische Aminosäuren als Zwischenstufen und Verfahren zu deren Herstellung
DE2821242C2 (enrdf_load_stackoverflow)
DE69121000T2 (de) Alpha-Mannosidase- und fucosidase-Hemmer
DE19604920A1 (de) Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
US5382709A (en) Alpha-mannosidase and fucosidase inhibitors
DE60216239T2 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
EP0749970B1 (de) Benzisothiazolyl-substituierte Aminomethylchromane
DE69131522T2 (de) Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel
DE68911192T2 (de) Phosphonoalkylpurin-Derivate.
DE69008668T2 (de) Synthese von Mannojirimycin-Derivaten.
DE3721223C2 (enrdf_load_stackoverflow)
DE69219801T2 (de) 9-Aminotetrahydroakridinederivate und verwandte Derivate, Verfahren zur ihrer Herstellung und ihre Anwendung als Arzneimittel
DE69228259T2 (de) Neue alpha-mannosidase-inhibitoren
DE69617951T2 (de) Verabreichung von valienaminverwandten disaccharidverindungen zur verminderung von entzündungen bei säugern, die durch kontakt mit einem antigen sensibilisiert sind
DE69826881T2 (de) Neue indolcarboxamide, pharmazeutische zusammensetzungen und methoden zur hemmung von calpain
EP1234816B1 (de) Scyphostatin-Analoga als SMase-Inhibitoren
DE69120705T2 (de) Hydroxymethyl-indolizidine und -chinolizidine
DE2729165C2 (de) Phenäthylaminderivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0491263A1 (de) Phenylalkylaminoalkyl-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE60132981T2 (de) Duale moleküle enthaltend ein peroxydderivat,deren synthese und deren verwendung als heilmittel
DE69300011T2 (de) Diacylglycerol-Nicotinate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE3146867C2 (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee